<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2025.1596403</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Establishment of a prediction model for long-term infections in patients undergoing peritoneal dialysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Mengmeng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<xref ref-type="author-notes" rid="fn004"><sup>&#x2021;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/3006928/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Lu</surname> <given-names>Qian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sun</surname> <given-names>Jinzhu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Dai</surname> <given-names>Shengnan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yan</surname> <given-names>Feng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yang</surname> <given-names>Chun</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c003"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname> <given-names>Qiuhua</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Nephrology, Wuxi No.2 People&#x2019;s Hospital, Jiangnan University Medical Center</institution>, <addr-line>Wuxi</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Urology, Wuxi No.2 People&#x2019;s Hospital, Jiangnan University Medical Center</institution>, <addr-line>Wuxi</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Ashish Verma, EVERSANA India Pvt. Ltd., India</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Xinling Pan, Dongyang Hospital of Wenzhou Medical University, China</p><p>Jatin Pruthi, EVERSANA India Pvt. Ltd., India</p></fn>
<corresp id="c001">&#x002A;Correspondence: Qiuhua Zhang, <email>qhzhang02170633@163.com</email></corresp>
<corresp id="c002">Feng Yan, <email>YF2250@126.com</email></corresp>
<corresp id="c003">Chun Yang, <email>yang-chun@126.com</email></corresp>
<fn fn-type="equal" id="fn002"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
<fn fn-type="other" id="fn004"><p><sup>&#x2021;</sup>ORCID: Mengmeng Liu, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0009-0005-3494-8881">orcid.org/0009-0005-3494-8881</ext-link></p></fn></author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1596403</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>03</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>05</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Liu, Lu, Sun, Dai, Yan, Yang and Zhang.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Liu, Lu, Sun, Dai, Yan, Yang and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec>
<title>Background and Objective</title>
<p>Peritoneal dialysis (PD)-associated infections are the primary contributors to PD technique failure and patient mortality. Given these reasons, this study aims to identify independent risk factors for long-term infections in PD individuals and to construct an effective clinical prediction model using multivariate analysis.</p>
</sec>
<sec>
<title>Methods</title>
<p>This study retrospectively analyzed 214 participants with ESRD who underwent PD catheterization at Wuxi No. 2 People&#x2019;s Hospital. Based on whether they developed infections or not after 3 months treatment of regular peritoneal dialysis, all patients were categorized into two cohorts: infected (<italic>n</italic> = 67) and non-infected (<italic>n</italic> = 147). A comparison of clinical indicators was made between the two cohorts, and independent risk factors were initially determined through the means of univariate and multivariate logistic regression analyses for infections in PD patients. Via R software, we constructed a nomogram prediction model, its performance was validated.</p>
</sec>
<sec>
<title>Results</title>
<p>Age (<italic>p</italic> = 0.004), surgical incision length (<italic>p</italic> = 0.018), and Prognostic Nutritional Index (PNI,<italic> p</italic> &#x003C; 0.001) were identified as independent risk factors for long-term infections in PD patients. Based on the three significant predictors, we constructed a nomogram model, of which predictive performance was assessed through analysis of the ROC curve, which revealed area under the curve (AUC) values of 0.807, demonstrating good discriminative ability of the prediction model for long-term infection risk in PD patients.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Advanced age, lower PNI, and longer surgical incision length are closely linked to the occurrence of infections in PD individuals. The nomogram model which was based on this study showed high efficacy in predicting long-term infections and can serve as a reference to recognize individuals with a high likelihood of complications for medical caregivers as early as possible.</p>
</sec>
</abstract>
<kwd-group>
<kwd>end-stage renal disease</kwd>
<kwd>peritoneal dialysis</kwd>
<kwd>long-term infection</kwd>
<kwd>prediction model</kwd>
<kwd>nomogram</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="31"/>
<page-count count="10"/>
<word-count count="5153"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nephrology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>1 Introduction</title>
<p>Recent evidence suggests that there has been a rapid growth in the number of people with ESRD in China, resulting in a significant rise in total count of patients undergoing dialysis (<xref ref-type="bibr" rid="B1">1</xref>). By the end of 2023, China was reported to have the highest total of individuals receiving dialysis globally, with over 1.06 million registered for either hemodialysis or peritoneal dialysis. Between 2013 and 2023, the number of patients undergoing PD increased by 108,000. PD accounts for approximately 11% of dialysis cases globally and is a key renal replacement therapy for ESRD patients (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). PD utilizes the semipermeable nature of the peritoneum to remove toxins and metabolic waste through diffusion and convection, thereby achieving blood purification (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). Compared to hemodialysis, PD offers several advantages, including the convenience of home treatment, ease of operation, supported conservation of remaining renal function, and safety (<xref ref-type="bibr" rid="B6">6</xref>). As a result, it is widely recognized and promoted by numerous experts in the field. However, studies indicate that patients with ESRD have no less than 50% probability of experiencing one or more infections during dialysis (<xref ref-type="bibr" rid="B7">7</xref>), which are among the leading causes of discontinuation of dialysis treatment and increased mortality&#x2013;second only to cardiovascular disease. Infections related to PD are a major factor influencing prognosis (<xref ref-type="bibr" rid="B8">8</xref>). Predicting and identifying patients at high risk of PD-related infections, followed by timely intervention, is essential for improving survival rates, quality of life, and overall outcomes. We aimed to develop a high-performing model which is able to help predict the underlying risk elements of long-term infections in patients undergoing PD using advanced statistical methods and big data investigation.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>2 Materials and methods</title>
<sec id="S2.SS1">
<title>2.1 Study design and participants</title>
<p>214 participants with ESRD who underwent PD catheterization and received regular PD treatment for over 3 months at Wuxi No. 2 People&#x2019;s Hospital from June 2017 to June 2024 were parts of this study. The primary endpoint of our study is the occurrence of infections in PD patients during the observation period from June 2017 to June 2024. Based on patients&#x2019; infection status after 3 months of PD, they were categorized into an infection group and a non-infection one. Infections primarily included intra-abdominal, skin, and catheter-related infections (tunnel and exit-site infections). The Ethics Committee of Wuxi No. 2 People&#x2019;s Hospital (Ethics Approval No.2023Y-3) issued strong approval for the ethical conduct of this study. Inclusion criteria: (1) diagnosed with ESRD based on a glomerular filtration rateless than 15 ml/(min.1.73 m<sup>2</sup>), (2) treated with PD following the &#x201C;Chinese Guidelines for Peritoneal Dialysis Catheterization&#x201D; with a treatment duration of &#x2265; 3 months (<xref ref-type="bibr" rid="B9">9</xref>), (3) aged 18&#x2013;85 years, (4) complete clinical laboratory and imaging examination data available, (5) signed informed consent. Exclusion criteria: (1) lack of regular follow-up at the hospital, (2) severe cardiopulmonary dysfunction, (3) severe intra-abdominal infections (occurring after PD catheter placement surgery but before the initiation of the first PD treatment) or adhesions, (4) pregnancy, and (5) failure to sign informed consent.</p>
</sec>
<sec id="S2.SS2">
<title>2.2 Data collection</title>
<p>At the time of admission, relevant examinations were conducted, and general data were collected. These comprised essential information (age, gender, weight, height, BMI), laboratory results (serum creatinine, blood urea nitrogen, serum sodium, serum potassium, albumin and other blood count results), surgical-related indicators (operative time, intraoperative blood loss, surgical incision length, postoperative hospitalization duration, surgery costs, surgery costs/total costs), and peritoneal dialysis-related complications (catheter flow dysfunction, dialysate leakage, catheter migration, exit-site infections, and abdominal catheter tunnel infection).</p>
</sec>
<sec id="S2.SS3">
<title>2.3 Nomogram for individualized prediction</title>
<p>We carried out multivariable logistic regression analysis with stepwise selection guided by the Akaike Information Criterion (AIC) to identify independent risk factors for infections in PD patients. Variables demonstrating statistical significance (<italic>p</italic> &#x003C; 0.05) were retained as independent predictors. Random forest plotting was subsequently implemented to visualize predictor accuracy and variable importance metrics, which were ultimately integrated into a nomogram for predicting infection risk in PD patients. We plotted the ROC curve and evaluated the model&#x2019;s discriminative ability by calculating the area under the curve (AUC). Additionally, calibration performance was quantified via 1,000-round bootstrap validation of calibration curves, while decision curve analysis (DCA) was carried out by calculating standardized net benefits across varying threshold probabilities to evaluate the clinical utility of the nomogram (<xref ref-type="bibr" rid="B10">10</xref>), which compensates for the limitations of ROC curves (<xref ref-type="bibr" rid="B11">11</xref>).</p>
</sec>
<sec id="S2.SS4">
<title>2.4 Statistical methods</title>
<p>We used SPSS 20.0 statistical to make an analysis of the classified and structured data. Continuous variables were expressed as mean &#x00B1; standard deviation or median (interquartile range, IQR), depending on normality. We made use of <italic>t</italic>-test or Mann-Whitney U test to compare the means or medians across different sets. With respect to categorical variables, the data were presented in terms of frequency counts and percentage, at the same time, the implementation of Pearson&#x2019;s chi-square test facilitated a comprehensive evaluation of the variations identified between the two groups. Odds ratios (ORs), often with 95% confidence intervals (CIs), were used to present the entire set of findings. Univariate analysis was performed using Pearson&#x2019;s chi-square test or Fisher&#x2019;s exact test, as appropriate. Variables with statistically significant differences (<italic>p</italic> &#x003C; 0.05) were included in a multivariate logistic regression model (backward direction) to identify independent risk factors for long-term infection in PD patients. And validation of the nomogram were executed using R software (x64 for Windows, version 3.6.1). In all analyses, a two-sided <italic>p</italic>-value &#x003C; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="S3">
<title>3 Result</title>
<sec id="S3.SS1">
<title>3.1 Baseline characteristics of patients</title>
<p>235 individuals with ESRD who underwent PD were initially screened. Following the screening process, 214 participants satisfying the inclusion criteria were finally included. The procedural steps involved in the data selection process are depicted in the flowchart feature in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>The flow chart of study design and patient selection.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1596403-g001.tif"/>
</fig>
<p>We collected clinical data from 214 patients with ESRD undergoing regular peritoneal dialysis. Based on the follow-up results after 3 months of PD treatment, all participants were stratified into infection and non-infection groups. Significant intergroup differences were observed in the following aspects: age, serum albumin, PNI, GNRI, surgery-related indicators (surgical duration, intraoperative bleeding volume, surgical incision length), primary disease and peritoneal dialysis-associated complications [exit-site infection (ESI) and abdominal catheter tunnel infection] (all with <italic>p</italic> &#x003C; 0.05). Individuals in the infection group were older than those in the non-infection one (57.81 &#x00B1; 11.95 years vs. 52.25 &#x00B1; 13.29 years). Moreover, the infection group exhibited significantly longer surgical incision lengths (3.28 &#x00B1; 0.93 cm vs. 2.83 &#x00B1; 0.82 cm) and lower PNI values (37.04 &#x00B1; 6.00 vs. 41.99 &#x00B1; 4.97) compared to the non-infection group. In both groups, diabetic nephropathy was documented as the second most frequent primary disease, highlighting its substantial impact (<xref ref-type="bibr" rid="B12">12</xref>). There were no statistically significant intergroup differences in: hematologic indicators (serum creatinine, blood urea nitrogen, serum sodium, serum calcium, etc.), peritoneal dialysis-related complications (catheter malfunction, dialysate leakage, catheter migration). The clinical features of both groups are shown in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Baseline characteristics of patients.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Characteristics</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">No infection (<italic>n</italic> = 147)</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Infection (<italic>n</italic> = 67)</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><italic>P</italic>-value</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age, mean &#x00B1; sd</td>
<td valign="top" align="center">52.25 &#x00B1; 13.29</td>
<td valign="top" align="center">57.81 &#x00B1; 11.95</td>
<td valign="top" align="center">0.004</td>
</tr>
<tr>
<td valign="top" align="left">Gender (Female 0, Male 1), <italic>n</italic> (%)</td>
<td/>
<td/>
<td valign="top" align="center">0.124</td>
</tr>
<tr>
<td valign="top" align="left">0</td>
<td valign="top" align="center">60.00 (40.80%)</td>
<td valign="top" align="center">20.00 (29.90%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="center">87.00 (59.20%)</td>
<td valign="top" align="center">47.00 (70.10%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Height,cm, median (IQR)</td>
<td valign="top" align="center">167.00 (160.00, 173.00)</td>
<td valign="top" align="center">165.00 (160.00, 172.00)</td>
<td valign="top" align="center">0.630</td>
</tr>
<tr>
<td valign="top" align="left">Weight, median (IQR)</td>
<td valign="top" align="center">64.00 (56.50, 72.00)</td>
<td valign="top" align="center">62.50 (55.00, 73.50)</td>
<td valign="top" align="center">0.638</td>
</tr>
<tr>
<td valign="top" align="left">BMI, median (IQR)</td>
<td valign="top" align="center">22.66 (20.76, 25.07)</td>
<td valign="top" align="center">23.57 (21.22, 25.78)</td>
<td valign="top" align="center">0.170</td>
</tr>
<tr>
<td valign="top" align="left">Serum creatinine, mean &#x00B1; sd</td>
<td valign="top" align="center">816.20 &#x00B1; 333.27</td>
<td valign="top" align="center">839.06 &#x00B1; 291.46</td>
<td valign="top" align="center">0.629</td>
</tr>
<tr>
<td valign="top" align="left">Blood urea nitrogen, mean &#x00B1; sd</td>
<td valign="top" align="center">36.44 &#x00B1; 47.96</td>
<td valign="top" align="center">32.28 &#x00B1; 10.93</td>
<td valign="top" align="center">0.484</td>
</tr>
<tr>
<td valign="top" align="left">Serum sodium, mean &#x00B1; sd</td>
<td valign="top" align="center">139.75 &#x00B1; 3.17</td>
<td valign="top" align="center">139.79 &#x00B1; 3.59</td>
<td valign="top" align="center">0.934</td>
</tr>
<tr>
<td valign="top" align="left">Serum potassium, mean &#x00B1; sd</td>
<td valign="top" align="center">8.00 &#x00B1; 42.61</td>
<td valign="top" align="center">4.59 &#x00B1; 0.77</td>
<td valign="top" align="center">0.514</td>
</tr>
<tr>
<td valign="top" align="left">Serum calcium, mean &#x00B1; sd</td>
<td valign="top" align="center">1.99 &#x00B1; 0.26</td>
<td valign="top" align="center">1.98 &#x00B1; 0.28</td>
<td valign="top" align="center">0.844</td>
</tr>
<tr>
<td valign="top" align="left">Serum phosphorus, mean &#x00B1; sd</td>
<td valign="top" align="center">2.57 &#x00B1; 8.43</td>
<td valign="top" align="center">1.93 &#x00B1; 0.54</td>
<td valign="top" align="center">0.540</td>
</tr>
<tr>
<td valign="top" align="left">Serum albumin, mean &#x00B1; sd</td>
<td valign="top" align="center">36.33 &#x00B1; 4.72</td>
<td valign="top" align="center">31.77 &#x00B1; 5.44</td>
<td valign="top" align="center">2.252e&#x2212;09</td>
</tr>
<tr>
<td valign="top" align="left">Blood PTH, mean &#x00B1; sd</td>
<td valign="top" align="center">428.16 &#x00B1; 330.10</td>
<td valign="top" align="center">492.57 &#x00B1; 455.78</td>
<td valign="top" align="center">0.247</td>
</tr>
<tr>
<td valign="top" align="left">Total cholesterol (mmol), mean &#x00B1; sd</td>
<td valign="top" align="center">4.28 &#x00B1; 1.31</td>
<td valign="top" align="center">4.14 &#x00B1; 1.15</td>
<td valign="top" align="center">0.453</td>
</tr>
<tr>
<td valign="top" align="left">White blood cell count (&#x00D7; 10<sup>9</sup>), mean &#x00B1; sd</td>
<td valign="top" align="center">6.46 &#x00B1; 2.90</td>
<td valign="top" align="center">6.37 &#x00B1; 1.92</td>
<td valign="top" align="center">0.815</td>
</tr>
<tr>
<td valign="top" align="left">Neutrophil count (10<sup>9</sup>), mean &#x00B1; sd</td>
<td valign="top" align="center">4.64 &#x00B1; 2.73</td>
<td valign="top" align="center">4.62 &#x00B1; 1.73</td>
<td valign="top" align="center">0.957</td>
</tr>
<tr>
<td valign="top" align="left">Lymphocyte count (10<sup>9</sup>), mean &#x00B1; sd</td>
<td valign="top" align="center">1.13 &#x00B1; 0.50</td>
<td valign="top" align="center">1.05 &#x00B1; 0.50</td>
<td valign="top" align="center">0.297</td>
</tr>
<tr>
<td valign="top" align="left">NRS score, mean &#x00B1; sd</td>
<td valign="top" align="center">0.44 &#x00B1; 0.69</td>
<td valign="top" align="center">0.60 &#x00B1; 1.10</td>
<td valign="top" align="center">0.293</td>
</tr>
<tr>
<td valign="top" align="left">Hemoglobin, mean &#x00B1; sd</td>
<td valign="top" align="center">85.14 &#x00B1; 17.88</td>
<td valign="top" align="center">82.43 &#x00B1; 21.86</td>
<td valign="top" align="center">0.341</td>
</tr>
<tr>
<td valign="top" align="left">Platelet count, mean &#x00B1; sd</td>
<td valign="top" align="center">188.84 &#x00B1; 72.24</td>
<td valign="top" align="center">177.96 &#x00B1; 82.77</td>
<td valign="top" align="center">0.330</td>
</tr>
<tr>
<td valign="top" align="left">PNI, mean &#x00B1; sd</td>
<td valign="top" align="center">41.99 &#x00B1; 4.97</td>
<td valign="top" align="center">37.04 &#x00B1; 6.00</td>
<td valign="top" align="center">1.553e&#x2212;09</td>
</tr>
<tr>
<td valign="top" align="left">GNRI, mean &#x00B1; sd</td>
<td valign="top" align="center">98.65 &#x00B1; 10.07</td>
<td valign="top" align="center">92.42 &#x00B1; 10.90</td>
<td valign="top" align="center">6.071e&#x2212;05</td>
</tr>
<tr>
<td valign="top" align="left">Surgical duration (minutes), median (IQR)</td>
<td valign="top" align="center">36.00 (30.00, 50.00)</td>
<td valign="top" align="center">50.00 (32.00, 54.00)</td>
<td valign="top" align="center">0.002</td>
</tr>
<tr>
<td valign="top" align="left">Intraoperative bleeding volume (ml), median (IQR)</td>
<td valign="top" align="center">10.00 (9.00, 30.00)</td>
<td valign="top" align="center">30.00 (10.00, 32.00)</td>
<td valign="top" align="center">0.002</td>
</tr>
<tr>
<td valign="top" align="left">Surgical incision length (cm), mean &#x00B1; sd</td>
<td valign="top" align="center">2.83 &#x00B1; 0.82</td>
<td valign="top" align="center">3.28 &#x00B1; 0.93</td>
<td valign="top" align="center">0.000</td>
</tr>
<tr>
<td valign="top" align="left">Postoperative hospitalization time (days), mean &#x00B1; sd</td>
<td valign="top" align="center">6.59 &#x00B1; 3.55</td>
<td valign="top" align="center">7.09 &#x00B1; 3.75</td>
<td valign="top" align="center">0.351</td>
</tr>
<tr>
<td valign="top" align="left">Total hospitalization time (days), mean &#x00B1; sd</td>
<td valign="top" align="center">12.42 &#x00B1; 3.02</td>
<td valign="top" align="center">13.12 &#x00B1; 2.78</td>
<td valign="top" align="center">0.107</td>
</tr>
<tr>
<td valign="top" align="left">Surgical cost (yuan), mean &#x00B1; sd</td>
<td valign="top" align="center">1137.60 &#x00B1; 1114.20</td>
<td valign="top" align="center">1139.80 &#x00B1; 1013.30</td>
<td valign="top" align="center">0.989</td>
</tr>
<tr>
<td valign="top" align="left">Total hospitalization expenses (yuan), mean &#x00B1; sd</td>
<td valign="top" align="center">1.71 &#x00B1; 6550.10</td>
<td valign="top" align="center">1.77 &#x00B1; 5536.40</td>
<td valign="top" align="center">0.513</td>
</tr>
<tr>
<td valign="top" align="left">Surgical cost/total cost (%), mean &#x00B1; sd</td>
<td valign="top" align="center">0.07 &#x00B1; 0.06</td>
<td valign="top" align="center">0.06 &#x00B1; 0.03</td>
<td valign="top" align="center">0.385</td>
</tr>
<tr>
<td valign="top" align="left">Previous history of abdominal surgery, <italic>n</italic> (%)</td>
<td/>
<td/>
<td valign="top" align="center">0.711</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">129.00 (88.40%)</td>
<td valign="top" align="center">58.00 (86.60%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">17.00 (11.60%)</td>
<td valign="top" align="center">9.00 (13.40%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Primary disease (0: chronic nephritis 1: diabetes nephropathy 2: hypertensive nephropathy 3: others), <italic>n</italic> (%)</td>
<td/>
<td/>
<td valign="top" align="center">0.047</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="center">102.00 (69.40%)</td>
<td valign="top" align="center">41.00 (61.20%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">0</td>
<td valign="top" align="center">8.00 (5.40%)</td>
<td valign="top" align="center">9.00 (13.40%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="center">36.00 (24.50%)</td>
<td valign="top" align="center">14.00 (20.90%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="center">1.00 (0.70%)</td>
<td valign="top" align="center">3.00 (4.50%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Catheter flow dysfunction, <italic>n</italic> (%)</td>
<td/>
<td/>
<td valign="top" align="center">1.000</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">139.00 (94.60%)</td>
<td valign="top" align="center">64.00 (95.50%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">8.00 (5.40%)</td>
<td valign="top" align="center">3.00 (4.50%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Dialysate leakage, <italic>n</italic> (%)</td>
<td/>
<td/>
<td valign="top" align="center">0.579</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">144.00 (98.00%)</td>
<td valign="top" align="center">64.00 (95.50%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">3.00 (2.00%)</td>
<td valign="top" align="center">3.00 (4.50%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Catheter migration, <italic>n</italic> (%)</td>
<td/>
<td/>
<td valign="top" align="center">0.798</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">143.00 (97.30%)</td>
<td valign="top" align="center">64.00 (95.50%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">4.00 (2.70%)</td>
<td valign="top" align="center">3.00 (4.50%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Exit-site infection (ESI), <italic>n</italic> (%)</td>
<td/>
<td/>
<td valign="top" align="center">2.199e&#x2212;20</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">147.00 (100.00%)</td>
<td valign="top" align="center">34.00 (50.70%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">0.00 (0.00%)</td>
<td valign="top" align="center">33.00 (49.30%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Abdominal catheter tunnel infection, <italic>n</italic> (%)</td>
<td/>
<td/>
<td valign="top" align="center">0.001</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">147.00 (100.00%)</td>
<td valign="top" align="center">61.00 (91.00%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">0.00 (0.00%)</td>
<td valign="top" align="center">6.00 (9.00%)</td>
<td/>
</tr>
</tbody>
</table></table-wrap>
</sec>
<sec id="S3.SS2">
<title>3.2 Independent risk factors for long-term infection in PD</title>
<p>Univariate and multivariate logistic regression analyses were executed in both groups (<xref ref-type="table" rid="T2">Table 2</xref>). Univariate logistic regression analysis indicated that patient age, operative time for PD catheterization, surgical incision length, intraoperative blood loss, PNI, and GPNI emerged as independent potential risk indicators for infection in patients undergoing PD (all <italic>p</italic> &#x003C; 0.05). We threw these variables into a multivariate logistic regression analysis to pick out independent factors related to long-term infections in these patients, including age, surgical incision length and PNI. A random forest plot was developed to further assess the precision and significance of these predictive variables. As is shown in <xref ref-type="fig" rid="F2">Figure 2</xref>, increasing patient age (OR = 1.042, 95% CI: 1.013&#x2013;1.072, <italic>p</italic> = 0.004), longer surgical incision length (OR = 2.366, 95% CI: 1.161&#x2013;4.824, <italic>p</italic> = 0.018), in addition, lower PNI (OR = 0.785, 95% CI: 0.702&#x2013;0.878, <italic>p</italic> &#x003C; 0.001) were elements that increase susceptibility for long-term infection in patients undergoing PD.</p>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>Univariable and multivariable logistic regression analysis of patients with infections undergoing peritoneal dialysis.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;"></td>
<td valign="top" align="center" colspan="3" style="color:#ffffff;background-color: #7f8080;">Univariate analysis</td>
<td valign="top" align="center" colspan="2" style="color:#ffffff;background-color: #7f8080;">Multivariate analysis</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;"><bold>Characteristics</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>Total (<italic>N</italic>)</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>OR (95% CI) Univariate analysis</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold><italic>P</italic>-value</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>OR (95% CI) Multivariate analysis</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold><italic>P</italic>-value</bold></td>
</tr>
<tr>
<td valign="top" align="left">Age</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.034 (1.010&#x2013;1.059)</td>
<td valign="top" align="center">0.005</td>
<td valign="top" align="center">1.042 (1.013&#x2013;1.072)</td>
<td valign="top" align="center">0.004</td>
</tr>
<tr>
<td valign="top" align="left">Gender</td>
<td valign="top" align="center">214</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Female</td>
<td valign="top" align="center">80</td>
<td valign="top" align="center">Reference</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Male</td>
<td valign="top" align="center">134</td>
<td valign="top" align="center">1.621 (0.874&#x2013;3.007)</td>
<td valign="top" align="center">0.126</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Height</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.003 (0.981&#x2013;1.025)</td>
<td valign="top" align="center">0.811</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Weight</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.999 (0.978&#x2013;1.020)</td>
<td valign="top" align="center">0.910</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">BMI</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.047 (0.968&#x2013;1.133)</td>
<td valign="top" align="center">0.247</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Serum creatinine</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.000 (0.999&#x2013;1.001)</td>
<td valign="top" align="center">0.628</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Blood urea nitrogen</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.996 (0.986&#x2013;1.007)</td>
<td valign="top" align="center">0.511</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Serum sodium</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.004 (0.919&#x2013;1.096)</td>
<td valign="top" align="center">0.934</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Serum potassium</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.993 (0.955&#x2013;1.031)</td>
<td valign="top" align="center">0.703</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Serum calcium</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.897 (0.306&#x2013;2.631)</td>
<td valign="top" align="center">0.843</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Serum phosphorus</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.974 (0.874&#x2013;1.086)</td>
<td valign="top" align="center">0.637</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Serum albumin</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.831 (0.775&#x2013;0.890)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.817 (0.741&#x2013;0.900)</td>
<td valign="top" align="center">0.068</td>
</tr>
<tr>
<td valign="top" align="left">Blood PTH</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.000 (1.000&#x2013;1.001)</td>
<td valign="top" align="center">0.251</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Total cholesterol (mmol)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.913 (0.720&#x2013;1.157)</td>
<td valign="top" align="center">0.452</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">White blood cell count (&#x00D7; 10<sup>9</sup>)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.987 (0.882&#x2013;1.104)</td>
<td valign="top" align="center">0.814</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Neutrophil count (10<sup>9</sup>)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.997 (0.885&#x2013;1.122)</td>
<td valign="top" align="center">0.956</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Lymphocyte count (10<sup>9</sup>)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.726 (0.398&#x2013;1.324)</td>
<td valign="top" align="center">0.296</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Hemoglobin</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.993 (0.978&#x2013;1.008)</td>
<td valign="top" align="center">0.340</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">NRS score</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.230 (0.885&#x2013;1.709)</td>
<td valign="top" align="center">0.217</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Platelets</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.998 (0.994&#x2013;1.002)</td>
<td valign="top" align="center">0.330</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">PNI</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.841 (0.789&#x2013;0.896)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.785 (0.702&#x2013;0.878)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">GNRI</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.941 (0.911&#x2013;0.971)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.011 (0.967&#x2013;1.058)</td>
<td valign="top" align="center">0.622</td>
</tr>
<tr>
<td valign="top" align="left">Operation time (minutes)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.042 (1.015&#x2013;1.071)</td>
<td valign="top" align="center">0.002</td>
<td valign="top" align="center">1.033 (0.940&#x2013;1.136)</td>
<td valign="top" align="center">0.498</td>
</tr>
<tr>
<td valign="top" align="left">Intraoperative blood loss (ml)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.042 (1.015&#x2013;1.070)</td>
<td valign="top" align="center">0.002</td>
<td valign="top" align="center">1.073 (0.880&#x2013;1.307)</td>
<td valign="top" align="center">0.486</td>
</tr>
<tr>
<td valign="top" align="left">Surgical incision length (cm)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.834 (1.293&#x2013;2.601)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">2.366 (1.161&#x2013;4.824)</td>
<td valign="top" align="center">0.018</td>
</tr>
<tr>
<td valign="top" align="left">Postoperative hospitalization time (days)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.038 (0.960&#x2013;1.124)</td>
<td valign="top" align="center">0.350</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Total hospitalization time (days)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.085 (0.982&#x2013;1.198)</td>
<td valign="top" align="center">0.108</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Surgical cost (yuan)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.000 (1.000&#x2013;1.000)</td>
<td valign="top" align="center">0.989</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Total hospitalization expenses (yuan)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">1.000 (1.000&#x2013;1.000)</td>
<td valign="top" align="center">0.511</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Surgical cost/total cost (%)</td>
<td valign="top" align="center">214</td>
<td valign="top" align="center">0.051 (0.000&#x2013;44.688)</td>
<td valign="top" align="center">0.389</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Previous history of abdominal surgery</td>
<td valign="top" align="center">214</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="center">188</td>
<td valign="top" align="center">Reference</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="center">26</td>
<td valign="top" align="center">1.177 (0.496&#x2013;2.797)</td>
<td valign="top" align="center">0.711</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Primary disease</td>
<td valign="top" align="center">214</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Chronic nephritis</td>
<td valign="top" align="center">17</td>
<td valign="top" align="center">Reference</td>
<td/>
<td valign="top" align="center">Reference</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Diabetes nephropathy</td>
<td valign="top" align="center">50</td>
<td valign="top" align="center">0.346 (0.111&#x2013;1.075)</td>
<td valign="top" align="center">0.067</td>
<td valign="top" align="center">0.310 (0.085&#x2013;1.132)</td>
<td valign="top" align="center">0.076</td>
</tr>
<tr>
<td valign="top" align="left">Hypertensive nephropathy</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">2.667 (0.229&#x2013;31.069)</td>
<td valign="top" align="center">0.434</td>
<td valign="top" align="center">2.372 (0.181&#x2013;31.022)</td>
<td valign="top" align="center">0.510</td>
</tr>
<tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="center">143</td>
<td valign="top" align="center">0.357 (0.129&#x2013;0.990)</td>
<td valign="top" align="center">0.048</td>
<td valign="top" align="center">0.358 (0.108&#x2013;1.191)</td>
<td valign="top" align="center">0.094</td>
</tr>
<tr>
<td valign="top" align="left">Surgical approach</td>
<td valign="top" align="center">214</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Laparoscopy</td>
<td valign="top" align="center">14</td>
<td valign="top" align="center">Reference</td>
<td/>
<td valign="top" align="center">Reference</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Laparotomy</td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">4.345 (0.923&#x2013;20.444)</td>
<td valign="top" align="center">0.063</td>
<td valign="top" align="center">0.835 (0.006&#x2013;119.240)</td>
<td valign="top" align="center">0.943</td>
</tr>
<tr>
<td valign="top" align="left">Percutaneous puncture</td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">1.792 (0.374&#x2013;8.595)</td>
<td valign="top" align="center">0.466</td>
<td valign="top" align="center">7.716 (0.859&#x2013;69.314)</td>
<td valign="top" align="center">0.068</td>
</tr>
</tbody>
</table></table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Multivariate logistic regression analysis of patients with infections undergoing peritoneal dialysis.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1596403-g002.tif"/>
</fig>
</sec>
<sec id="S3.SS3">
<title>3.3 Development and analysis of the nomogram model</title>
<p>As illustrated in <xref ref-type="fig" rid="F3">Figure 3</xref>, based on the three independent predictive factors obtained from multivariable logistic regression, the nomogram model was rigorously formulated to predict infection risk in PD individuals. The results indicated that a PNI score of 20 corresponded to the highest risk score (100), followed by an incision length of 5 cm (43 points). When the risk factors for infections in patients are visualized, individual risks for developing long-term infections can be predicted. First, each independent risk factor contributing to infections in patients undergoing PD was projected onto the first row of the scale to derive scores for each factor, and by adding up the values of all 3 risk factors, total score was calculated. A higher total score indicates a higher risk of infection for these patients. The research sample was used as the training set, with 1,000 repeated samplings performed, and internal validation was conducted using five-fold cross-validation. As shown in <xref ref-type="fig" rid="F4">Figure 4A</xref>, the AUC value was 0.807 (95% CI: 0.746&#x2013;0.869), indicating that the model demonstrated good discriminative accuracy in predicting the risk of long-term infection in PD patients. The corresponding AUC values for PNI, surgical incision length, and age were 0.743, 0.636, and 0.619. Specifically, PNI exhibited higher predictive accuracy compared to surgical incision length and age (<xref ref-type="fig" rid="F4">Figure 4B</xref>). To evaluate the validity of the modeling results, a calibration plot for the infection risk prediction model in PD individuals was generated. <xref ref-type="fig" rid="F4">Figure 4C</xref> showed that the observed outcomes were in high agreement with the predicted outcomes. DCA was performed to assess its clinical utility. As illustrated in <xref ref-type="fig" rid="F4">Figure 4D</xref>, according to the decision curve, when the threshold probability for a specific patient ranged between 14 and 92%, the net benefit of this predictive model (red curve) was consistently higher than that of the &#x201C;All&#x201D; and &#x201C;None&#x201D; lines, demonstrating its practical value.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>Establishment of the nomogram for predicting infections in patients undergoing peritoneal dialysis.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1596403-g003.tif"/>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>Evaluation of the nomogram. <bold>(A)</bold> Area under the ROC curves (AUC) for the prediction of infections using the nomogram in patients undergoing peritoneal dialysis. <bold>(B)</bold> AUC for the prediction of infections using single indicator. <bold>(C)</bold> The calibration curve for the risk of infections. <bold>(D)</bold> Decision curve analysis (DCA) of the nomogram (red line).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1596403-g004.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>4 Discussion</title>
<p>The latest statistics released by the Chinese Center for Disease Control and Prevention in 2023 indicate that approximately 82 million adults in China suffer from chronic kidney disease (CKD). As renal function deteriorates in patients suffering from CKD, the condition may eventually progress to an irreversible phase known as ESRD, which necessitates ongoing renal replacement therapy, like dialysis or a kidney transplant, to maintain life. PD, a treatment method that prolongs the lives of patients with ESRD, helps preserve residual kidney function and improves their quality of life, contributing to its increased prevalence among patients with ESRD. Research suggests that over 272,000 patients worldwide are currently treated with PD (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). However, PD-related infections remain a significant threat to patient safety, potentially leading to catheter removal, changes in dialysis methods, or even life-threatening situations. Being one of the most frequently encountered complications, infection is the primary factor leading to the efficacy of dialysis (<xref ref-type="bibr" rid="B15">15</xref>). Infections occurring during PD can result in treatment failure and pose life-threatening risks. Consequently, it is of great significance and value for medical clinicians to rapidly and accurately detect the individuals who are at a high risk level, implement timely preventive measures targeting related risk factors, reduce infection rates, and improve patient prognosis and living standards (<xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>This study show that older age, longer PD catheterization incision lengths, and lower PNI are risk factors for infections in patients undergoing PD. Among these, PNI had the most significant impact on infection occurrence compared to age and incision length. PNI is a composite index that assesses the immune, inflammatory, and nutritional status of patients (<xref ref-type="bibr" rid="B17">17</xref>), and is worked out rooted in serum albumin and peripheral blood lymphocytes. It is widely used in prognostic assessments for various conditions, including cancer and cardiovascular diseases (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>). Previous research has brought to light that PNI takes on a major role in predicting outcomes for patients undergoing PD (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). Although preliminary small-scale studies have suggested an association between low PNI and the incidence of peritonitis in PD individuals, multicenter validation remains lacking, and a low PNI is key to predicting mortality in this population (<xref ref-type="bibr" rid="B23">23</xref>), which is consistent with the predictive directions of this study. Patients with ESRD undergoing long-term dialysis often experience malnutrition, largely due to dietary restrictions (low-protein diets), nutrient loss during dialysis, and increased catabolic metabolism due to inflammatory cytokines. The incidence of diseases stemming from malnutrition greatly affects patients&#x2019; health and well-being, and increases the risk of infection in individuals undergoing PD (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). Low nutritional status in these patients, coupled with anemia and hypoalbuminemia, creates a vicious cycle that exacerbates infection risk (<xref ref-type="bibr" rid="B26">26</xref>). So far, the criterion of PNI in the PD population has not been standardized, and whether interfering with the PNI factor can reduce the probability of infection in PD patients still requires further validation through large-sample, multicenter studies.</p>
<p>According to the latest data from the United States Renal Data System published in 2023, the highest incidence of ESRD is seen in individuals over 75 years of age. Older patients undergoing dialysis often have weakened immune systems and multisystem diseases, making them more susceptible to infections. Relevant studies have confirmed that older patients undergoing PD are more likely to develop infections than younger patients (<xref ref-type="bibr" rid="B27">27</xref>). Additionally, patients with ESRD over 60 years of age experience declining immune function, diminished quantity and reduced immune cell efficacy, and damage to the peritoneum caused by prolonged dialysis, often alongside ongoing health issues like diabetes, hypertension, and hemodynamic diseases. This results in reduced resistance to various pathogens, thereby increasing the likelihood of infections (<xref ref-type="bibr" rid="B28">28</xref>). A single-centre retrospective study also revealed that older patients had higher rates of peritonitis and associated mortality (<xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>The length of the incision used for PD catheterization is another contributing factor. Historically, open surgical methods were predominantly used for PD catheterization. However, open catheterization causes greater trauma to patients, with longer incisions significantly affecting postoperative recovery (<xref ref-type="bibr" rid="B30">30</xref>). For obese patients with ESRD, larger surgical incisions increase the risk of fat liquefaction and infection during recovery (<xref ref-type="bibr" rid="B31">31</xref>). Additionally, larger incisions provide a greater area for direct contact with the abdominal cavity. If sterile protocols are violated during surgery or postoperative care is inadequate, infections may occur, disrupting normal dialysis processes.</p>
<p>In summary, infections in patients undergoing PD are influenced by multiple factors including individual differences, treatment environments, and operational techniques. Predictive models cannot capture all these factors, limiting their generalizability across different patient populations or treatment contexts. Furthermore, another limitation of this study is that we did not investigate the types of pathogens (e.g., gram-positive and gram-negative bacteria) and the sites of infection (e.g., exit-site infection vs. peritonitis). Additionally, most current research focuses on constructing individualized predictive models within single centres, limiting their clinical applicability and accuracy. Further exploration is needed to optimize predictive models and establish personalized treatment plans that improve prognosis and quality of life for patients undergoing PD.</p>
</sec>
<sec id="S5" sec-type="conclusion">
<title>5 Conclusion</title>
<p>In conclusion, this study identified patient age, surgical incision length, and PNI as individual risk determinants for infections in patients receiving PD, which were used to construct a nomogram model. This model demonstrated good predictive efficacy for long-term infections in patients undergoing PD. Moreover, it can be employed as a valuable reference for clinical staff to detect high-risk individuals at an early stage, facilitating prompt interventions to reduce infection rates and improve outcomes.</p>
</sec>
</body>
<back>
<sec id="S6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in this study are included in this article/Supplementary material, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="S7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by the Ethics Committee of Wuxi No. 2 People&#x2019;s Hospital [Ethics No.: (2023) Ethical Review No. (Y-3)]. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="S8" sec-type="author-contributions">
<title>Author contributions</title>
<p>ML: Data curation, Visualization, Methodology, Conceptualization, Writing &#x2013; review and editing, Formal Analysis, Writing &#x2013; original draft, Investigation, Software. QL: Data curation, Formal Analysis, Writing &#x2013; review and editing. JS: Validation, Data curation, Formal Analysis, Investigation, Writing &#x2013; review and editing, Supervision. SD: Writing &#x2013; review and editing, Methodology, Formal Analysis, Investigation. FY: Methodology, Writing &#x2013; review and editing, Resources, Conceptualization, Supervision. CY: Investigation, Resources, Writing &#x2013; review and editing, Project administration, Supervision. QZ: Funding acquisition, Resources, Supervision, Conceptualization, Writing &#x2013; review and editing, Investigation.</p>
</sec>
<sec id="S9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. Funding for this research was provided by the Top Talent Support Program for young and middle-aged people of Wuxi Health Committee (HB2023029).</p>
</sec>
<ack><p>All authors participating in this research also wish to express their heartfelt gratitude to the patients who took part in this research.</p>
</ack>
<sec id="S10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="S11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The authors declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="S12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name> <name><surname>Feng</surname> <given-names>Y</given-names></name> <name><surname>Sun</surname> <given-names>W</given-names></name> <name><surname>Kong</surname> <given-names>Y</given-names></name> <name><surname>Jia</surname> <given-names>L</given-names></name></person-group>. <article-title>Antioxidation, anti-inflammation and anti-fibrosis effect of phosphorylated polysaccharides from <italic>Pleurotus djamor</italic> mycelia on adenine-induced chronic renal failure mice.</article-title> <source><italic>Int J Biol Macromol.</italic></source> (<year>2021</year>) <volume>170</volume>:<fpage>652</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.12.159</pub-id> <pub-id pub-id-type="pmid">33359803</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>Y</given-names></name> <name><surname>Bello</surname> <given-names>A</given-names></name> <name><surname>Levin</surname> <given-names>A</given-names></name> <name><surname>Lunney</surname> <given-names>M</given-names></name> <name><surname>Osman</surname> <given-names>M</given-names></name> <name><surname>Ye</surname> <given-names>F</given-names></name><etal/></person-group> <article-title>Peritoneal dialysis use and practice patterns: An international survey study.</article-title> <source><italic>Am J Kidney Dis.</italic></source> (<year>2021</year>) <volume>77</volume>:<fpage>315</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2020.05.032</pub-id> <pub-id pub-id-type="pmid">32800844</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di</surname> <given-names>Y</given-names></name> <name><surname>Jing, Lyu</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Guo</surname> <given-names>M</given-names></name> <name><surname>Ma</surname> <given-names>D</given-names></name></person-group>. <article-title>Influencing factors of peritoneal dialysis-associated peritonitis and nomogram prediction modeling.</article-title> <source><italic>J Clin Nephrol.</italic></source> (<year>2023</year>) <volume>23</volume>:<fpage>569</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1671-2390.2023.07.007</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><collab>Project Group of White Paper on the Status of Peritoneal Dialysis Management in China.</collab> <article-title>White paper on the current status of peritoneal dialysis management in China.</article-title> <source><italic>Chin J Nephrol.</italic></source> (<year>2022</year>) <volume>38</volume>:<fpage>1076</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.cn441217-20220418-00158</pub-id> <pub-id pub-id-type="pmid">30704229</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>Q</given-names></name></person-group>. <article-title>Progress of peritoneal dialysis catheterization.</article-title> <source><italic>Chin J Blood Purif.</italic></source> (<year>2022</year>) <volume>21</volume>:<fpage>309</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1671-4091.2022.05.002</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bello</surname> <given-names>AK</given-names></name> <name><surname>Okpechi</surname> <given-names>IG</given-names></name> <name><surname>Osman</surname> <given-names>MA</given-names></name> <name><surname>Cho</surname> <given-names>Y</given-names></name> <name><surname>Cullis</surname> <given-names>B</given-names></name> <name><surname>Htay</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Epidemiology of peritoneal dialysis outcomes.</article-title> <source><italic>Nat Rev Nephrol.</italic></source> (<year>2022</year>) <volume>18</volume>:<fpage>779</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1038/S41581-022-00623-7</pub-id> <pub-id pub-id-type="pmid">36114414</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen-Yuan</surname> <given-names>L</given-names></name> <name><surname>Juan-Jie</surname> <given-names>W</given-names></name> <name><surname>Dong</surname> <given-names>J</given-names></name></person-group>. <article-title>Influencing factors of infection in peritoneal dialysis patients and their risk prediction nomogram model.</article-title> <source><italic>Chin J Nosocomiol.</italic></source> (<year>2023</year>) <volume>33</volume>:<fpage>3185</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.11816/cn.ni.2023-230228</pub-id> <pub-id pub-id-type="pmid">36110322</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manera</surname> <given-names>K</given-names></name> <name><surname>Johnson</surname> <given-names>D</given-names></name> <name><surname>Craig</surname> <given-names>J</given-names></name> <name><surname>Shen</surname> <given-names>J</given-names></name> <name><surname>Gutman</surname> <given-names>T</given-names></name> <name><surname>Cho</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Establishing a core outcome set for peritoneal dialysis: Report of the SONG-PD (standardized outcomes in nephrology-peritoneal dialysis) consensus workshop.</article-title> <source><italic>Am J Kidney Dis.</italic></source> (<year>2020</year>) <volume>75</volume>:<fpage>404</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2019.09.017</pub-id> <pub-id pub-id-type="pmid">31955922</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><collab>Chinese Expert Group on Peritoneal Dialysis.</collab> <article-title>China guideline for peritoneal dialysis catheter insertion.</article-title> <source><italic>Chin J Nephrol.</italic></source> (<year>2016</year>) <volume>32</volume>:<fpage>867</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.1001-7097.2016.11.014</pub-id> <pub-id pub-id-type="pmid">30704229</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname> <given-names>M</given-names></name> <name><surname>Saville</surname> <given-names>B</given-names></name> <name><surname>Lewis</surname> <given-names>R</given-names></name></person-group>. <article-title>Decision curve analysis.</article-title> <source><italic>JAMA.</italic></source> (<year>2015</year>) <volume>313</volume>:<fpage>409</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2015.37</pub-id> <pub-id pub-id-type="pmid">25626037</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname> <given-names>K</given-names></name> <name><surname>Brown</surname> <given-names>M</given-names></name> <name><surname>Zhu</surname> <given-names>K</given-names></name> <name><surname>Janes</surname> <given-names>H</given-names></name></person-group>. <article-title>Assessing the clinical impact of risk prediction models with decision curves: Guidance for correct interpretation and appropriate use.</article-title> <source><italic>J Clin Oncol.</italic></source> (<year>2016</year>) <volume>34</volume>:<fpage>2534</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1200/.2015.65.5654</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Z</given-names></name></person-group>. <article-title>Nephrology in China.</article-title> <source><italic>Nat Rev Nephrol.</italic></source> (<year>2013</year>) <volume>9</volume>:<fpage>523</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nrneph.2013.146</pub-id> <pub-id pub-id-type="pmid">23877587</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Xu</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>M</given-names></name> <name><surname>Hu</surname> <given-names>C</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Prevalence of chronic kidney disease in China: Results from the sixth China chronic disease and risk factor surveillance.</article-title> <source><italic>JAMA Intern Med.</italic></source> (<year>2023</year>) <volume>183</volume>:<fpage>298</fpage>&#x2013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1001/jamainternmed.2022.6817</pub-id> <pub-id pub-id-type="pmid">36804760</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname> <given-names>H</given-names></name> <name><surname>Yang</surname> <given-names>J</given-names></name> <name><surname>Zou</surname> <given-names>R</given-names></name> <name><surname>An</surname> <given-names>N</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Yang</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Autophagy in peritoneal fibrosis.</article-title> <source><italic>Front Physiol.</italic></source> (<year>2023</year>) <volume>14</volume>:<fpage>1187207</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2023.1187207</pub-id> <pub-id pub-id-type="pmid">37256065</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blaine</surname> <given-names>E</given-names></name> <name><surname>Tumlinson</surname> <given-names>R</given-names></name> <name><surname>Colvin</surname> <given-names>M</given-names></name> <name><surname>Haynes</surname> <given-names>T</given-names></name> <name><surname>Whitley</surname> <given-names>H</given-names></name></person-group>. <article-title>Systematic literature review of insulin dose adjustments when initiating hemodialysis or peritoneal dialysis.</article-title> <source><italic>Pharmacotherapy.</italic></source> (<year>2022</year>) <volume>42</volume>:<fpage>177</fpage>&#x2013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1002/phar.2659</pub-id> <pub-id pub-id-type="pmid">35000222</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xingjuan</surname> <given-names>T</given-names></name> <name><surname>Yaqing</surname> <given-names>Z</given-names></name></person-group>. <article-title>Research progress in home-based assisted peritoneal dialysis.</article-title> <source><italic>Chin Nurs Manag.</italic></source> (<year>2019</year>) <volume>19</volume>:<fpage>773</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1672-1756.2019.05.028</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>Z</given-names></name> <name><surname>Jun</surname> <given-names>A</given-names></name> <name><surname>Shengwu</surname> <given-names>L</given-names></name> <name><surname>Shuting</surname> <given-names>T</given-names></name> <name><surname>Nirong</surname> <given-names>G</given-names></name> <name><surname>Yaozhong</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Association of prognostic nutritional index with cardiovascular mortality in patients with peritoneal dialysis: A multicenter retrospective cohort study.</article-title> <source><italic>Chin Gen Pract.</italic></source> (<year>2025</year>) <volume>28</volume>:<fpage>568</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.12114/j.issn.1007-9572.2024.0340</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Ma</surname> <given-names>W</given-names></name> <name><surname>Qiu</surname> <given-names>Z</given-names></name> <name><surname>Kuang</surname> <given-names>T</given-names></name> <name><surname>Wang</surname> <given-names>K</given-names></name> <name><surname>Hu</surname> <given-names>B</given-names></name><etal/></person-group> <article-title>Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors.</article-title> <source><italic>Front Immunol.</italic></source> (<year>2023</year>) <volume>14</volume>:<fpage>1219929</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2023.1219929</pub-id> <pub-id pub-id-type="pmid">37545502</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>J</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Huang</surname> <given-names>M</given-names></name> <name><surname>Ma</surname> <given-names>M</given-names></name> <name><surname>Huang</surname> <given-names>Q</given-names></name> <name><surname>Huang</surname> <given-names>N</given-names></name><etal/></person-group> <article-title>Prognostic value of prognostic nutritional index score and controlling nutritional status score in patients with glioblastoma: A comprehensive metaanalysis.</article-title> <source><italic>Front Oncol.</italic></source> (<year>2023</year>) <volume>13</volume>:<fpage>1117764</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2023.1117764</pub-id> <pub-id pub-id-type="pmid">36874094</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>J</given-names></name> <name><surname>Chen</surname> <given-names>C</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Zhai</surname> <given-names>X</given-names></name> <name><surname>Zhao</surname> <given-names>X</given-names></name> <name><surname>Ge</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>The association between the prognostic nutritional index and 28-day mortality among atrial fibrillation patients in China over 80 years of age.</article-title> <source><italic>Nutr Metab Cardiovasc Dis.</italic></source> (<year>2022</year>) <volume>32</volume>:<fpage>1493</fpage>&#x2013;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1016/j.numecd.2022.03.013</pub-id> <pub-id pub-id-type="pmid">35461750</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y</given-names></name> <name><surname>Zhou</surname> <given-names>H</given-names></name> <name><surname>Zhang</surname> <given-names>P</given-names></name> <name><surname>Chao</surname> <given-names>W</given-names></name> <name><surname>Zou</surname> <given-names>Y</given-names></name> <name><surname>Yang</surname> <given-names>M</given-names></name></person-group>. <article-title>Evaluation of objective nutritional indexes as predictors of worse outcomes in peritoneal dialysis patients.</article-title> <source><italic>Nutrition.</italic></source> (<year>2020</year>) <volume>79&#x2013;80</volume>:<fpage>110963</fpage>. <pub-id pub-id-type="doi">10.1016/j.nut.2020.110963</pub-id> <pub-id pub-id-type="pmid">33011471</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Tang</surname> <given-names>X</given-names></name> <name><surname>Tang</surname> <given-names>L</given-names></name> <name><surname>Shang</surname> <given-names>S</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>A low prognostic nutritional index is a risk factor for high peritoneal transport status in patients undergoing peritoneal dialysis.</article-title> <source><italic>J Ren Nutr.</italic></source> (<year>2023</year>) <volume>33</volume>:<fpage>201</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1053/j.jrn.2022.03.007</pub-id> <pub-id pub-id-type="pmid">35367359</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>L</given-names></name> <name><surname>Junlong</surname> <given-names>Z</given-names></name> <name><surname>Chaoting</surname> <given-names>W</given-names></name> <name><surname>Youdong</surname> <given-names>L</given-names></name> <name><surname>Jixian</surname> <given-names>Z</given-names></name> <name><surname>Xin</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>Comparison of domestic and international guidelines and consensus statements on nutritional recommendations for patients with kidney disease.</article-title> <source><italic>Mod Food Sci Technol.</italic></source> (<year>2023</year>) <volume>39</volume>:<fpage>386</fpage>&#x2013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.13982/j.mfst.1673-9078.2023.5.0784</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qing</surname> <given-names>Y</given-names></name> <name><surname>Ting-ting</surname> <given-names>F</given-names></name> <name><surname>Huan</surname> <given-names>L</given-names></name> <name><surname>Du</surname> <given-names>L</given-names></name></person-group>. <article-title>Effects of nutritional support on nutritional status and calcium and phosphorus metabolism in maintenance hemodialysis patients.</article-title> <source><italic>J Clin Nephrol.</italic></source> (<year>2024</year>) <volume>24</volume>:<fpage>827</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1671-2390.2024.10.005</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akhlaghi</surname> <given-names>Z</given-names></name> <name><surname>Sharifipour</surname> <given-names>F</given-names></name> <name><surname>Nematy</surname> <given-names>M</given-names></name> <name><surname>Safarian</surname> <given-names>M</given-names></name> <name><surname>Malekahmadi</surname> <given-names>M</given-names></name> <name><surname>Barkhidarian</surname> <given-names>B</given-names></name><etal/></person-group> <article-title>Assessment of nutritional status in maintenance hemodialysis patients: A multicenter cross-sectional study in Iran.</article-title> <source><italic>Semin Dial.</italic></source> (<year>2021</year>) <volume>34</volume>:<fpage>77</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1111/sdi.12917</pub-id> <pub-id pub-id-type="pmid">33058310</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juan</surname> <given-names>Z</given-names></name> <name><surname>Maolu</surname> <given-names>T</given-names></name> <name><surname>Cha</surname> <given-names>Y</given-names></name></person-group>. <article-title>Micro inflammatory status and erythropoietin low reactive anemia in maintenance hemodialysis patients.</article-title> <source><italic>Clin Focus.</italic></source> (<year>2023</year>) <volume>38</volume>:<fpage>949</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1004-583X.2023.10.017</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hongguang</surname> <given-names>Z</given-names></name> <name><surname>Hui</surname> <given-names>Q</given-names></name></person-group>. <article-title>Prevention and treatment of peritoneal dialysis-related peritonitis.</article-title> <source><italic>Chin J Kidney Dis Res.</italic></source> (<year>2015</year>) <volume>4</volume>:<fpage>22</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3877/cma.j.issn.2095-3216.2015.01.006</pub-id> <pub-id pub-id-type="pmid">39170172</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yangfan</surname> <given-names>Z</given-names></name> <name><surname>Min</surname> <given-names>Z</given-names></name></person-group>. <article-title>Analysis of Mycobacterium tuberculosis infection and risk factors in maintenance hemodialysis patients with end-stage renal disease.</article-title> <source><italic>Chin J Front Health Quarant.</italic></source> (<year>2024</year>) <volume>47</volume>:<fpage>600</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.16408/j.1004-9770.2024.06.013</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haishan</surname> <given-names>W</given-names></name> <name><surname>Hongjian</surname> <given-names>Y</given-names></name> <name><surname>Rong</surname> <given-names>H</given-names></name> <name><surname>Chunyan</surname> <given-names>Y</given-names></name> <name><surname>Juan</surname> <given-names>W</given-names></name> <name><surname>Xueqing</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Incidence and risk factors of peritoneal dialysis-related peritonitis in elderly patients: A retrospective clinical study.</article-title> <source><italic>Periton Dial Int.</italic></source> (<year>2020</year>) <volume>40</volume>:<fpage>26</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1177/0896860819879868</pub-id> <pub-id pub-id-type="pmid">32063144</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guoyi</surname> <given-names>W</given-names></name> <name><surname>Jinwen</surname> <given-names>Z</given-names></name> <name><surname>Haiyuan</surname> <given-names>L</given-names></name> <name><surname>Min</surname> <given-names>Z</given-names></name></person-group>. <article-title>Comparison of clinical effects of percutaneous catheterization and open catheterization in peritoneal dialysis with Seldinger method.</article-title> <source><italic>Anhui Med J.</italic></source> (<year>2022</year>) <volume>43</volume>:<fpage>1042</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1000-0399.2022.09.012</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ming-Ming</surname> <given-names>P</given-names></name> <name><surname>Yan</surname> <given-names>T</given-names></name> <name><surname>Ri-Ning</surname> <given-names>T</given-names></name> <name><surname>Hong</surname> <given-names>L</given-names></name> <name><surname>Mei-Xia</surname> <given-names>X</given-names></name> <name><surname>Xiao-Liang</surname> <given-names>ZL</given-names></name><etal/></person-group> <article-title>Evaluation of clinical application of percutaneous peritoneal dialysis catheterization under guidance of color ultrasonography.</article-title> <source><italic>J Clin Nephrol.</italic></source> (<year>2020</year>) <volume>20</volume>:<fpage>745</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1671-2390.2020.09.011</pub-id></citation></ref>
</ref-list>
</back>
</article>